{
    "organizations": [],
    "uuid": "2fed2fdc6439a103b1e7ab4fccef6a0bce9d32b8",
    "author": "",
    "url": "https://www.reuters.com/article/brief-aviragen-and-vaxart-amend-terms-of/brief-aviragen-and-vaxart-amend-terms-of-merger-agreement-to-increase-the-value-for-aviragen-stockholders-idUSFWN1PX1DZ",
    "ord_in_thread": 0,
    "title": "BRIEF-Aviragen And Vaxart Amend Terms Of Merger Agreement To Increase The Value For Aviragen Stockholders",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 7 (Reuters) - Aviragen Therapeutics Inc:\n* AVIRAGEN AND VAXART AMEND TERMS OF MERGER AGREEMENT TO INCREASE THE VALUE FOR AVIRAGEN STOCKHOLDERS\n* AVIRAGEN THERAPEUTICS INC - AVIRAGEN STOCKHOLDERS WOULD NOW OWN 49% OF COMBINED COMPANY, UP FROM 40% UNDER PREVIOUS AGREEMENT\n* AVIRAGEN THERAPEUTICS INC - AMENDED AGREEMENT HAS BEEN UNANIMOUSLY APPROVED BY BOARDS OF DIRECTORS OF BOTH COMPANIES\n* AVIRAGEN THERAPEUTICS INC - AVIRAGEN BOARD RECOMMENDS AVIRAGEN STOCKHOLDERS VOTE FOR MERGER AT SPECIAL MEETING OF STOCKHOLDERS ON FEBRUARY 9, 2018\n* AVIRAGEN THERAPEUTICS INC - ‍INTENDS TO RECONVENE SPECIAL MEETING OF STOCKHOLDERS TO VOTE ON PROPOSED MERGER ON FEB 9, 2018 AT 12:00 PM EST​ Source text for Eikon: Further company coverage:\n ",
    "published": "2018-02-07T22:39:00.000+02:00",
    "crawled": "2018-02-07T23:03:57.000+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "aviragen",
        "therapeutic",
        "inc",
        "aviragen",
        "vaxart",
        "amend",
        "term",
        "merger",
        "agreement",
        "increase",
        "value",
        "aviragen",
        "stockholder",
        "aviragen",
        "therapeutic",
        "inc",
        "aviragen",
        "stockholder",
        "would",
        "combined",
        "company",
        "previous",
        "agreement",
        "aviragen",
        "therapeutic",
        "inc",
        "amended",
        "agreement",
        "unanimously",
        "approved",
        "board",
        "director",
        "company",
        "aviragen",
        "therapeutic",
        "inc",
        "aviragen",
        "board",
        "recommends",
        "aviragen",
        "stockholder",
        "vote",
        "merger",
        "special",
        "meeting",
        "stockholder",
        "february",
        "aviragen",
        "therapeutic",
        "inc",
        "reconvene",
        "special",
        "meeting",
        "stockholder",
        "vote",
        "proposed",
        "merger",
        "feb",
        "pm",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}